Teva Launches Generic Actonel

Teva announced the launch of Risedronate Sodium Tablets, the generic version of Warner Chilcott’s Actonel.

Actonel is a bisphosphonate indicated for the treatment and prevention of osteoporosis in postmenopausal women. Actonel has an affinity for hydroxyapatite crystals in bone and acts as an antiresoprtive agent. At the cellular level, Actonel inhibits osteoclasts. The osteoclasts adhere normally to the bone surface, but show evidence of reduced active resorption. It also reduces bone turnover and bone resorption at remodeling sites.

RELATED: Oral Bisphosphonate Use May Lower Endometrial Cancer Risk

Risedronate Sodium is available in 5mg and 30mg strength tablets in 30-count bottles and in 35mg strength tablets in 4-count blister packs.

For more information call (888) 838-2872 or visit